Publisher
Springer Berlin Heidelberg
Reference39 articles.
1. Akimoto T, Ito K, Saitoh J-I et al (2005) Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity. Int J Radiat Oncol Biol Phys 62(2):463–471
2. Aström L, Pedersen D, Mercke C et al (2005) Long term outcome of high dose rate brachytherapy in radiotherapy of localized prostate cancer. Radiother Oncol 74:157–161
3. Bertermann H, Brix F (1990) Ultrasonically guided interstitial high dose brachytherapy with iridium-192: technique and preliminary results in locally confined prostate cancer. In: Martinez AA, Orton CG, Mould RF (eds) Brachytherapy HDR & LDR. Proceedings brachytherapy meeting remote afterloading: state of the art, Nucletron USA, Columbia. pp 281–301
4. Brindle JS, Martinez A, Schray M et al (1989) Pelvic lymphadenopathy and transperineal interstitial implantation of Ir192 combined with external beam radiotherapy for bulky stage C prostate carcinoma. Int J Radiat Oncol Biol Phys 17:1063–1066
5. Corner C, Rojas AM, Bryant L et al (2008) A phase II study of high-dose-rate afterloading brachytherapy as monotherapy for the treatment of localized prostate cancer. Int J Radiat Oncol Biol Phys 72:441–446